Analyst Price Targets — CRI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 19, 2026 1:31 pm | — | UBS | $40.00 | $41.60 | TheFly | Carter's price target raised to $40 from $33 at UBS |
| January 13, 2026 11:40 am | — | Goldman Sachs | $29.00 | $35.63 | TheFly | Carter's price target raised to $29 from $26 at Goldman Sachs |
| December 11, 2025 9:52 am | — | Goldman Sachs | $26.00 | $33.36 | TheFly | Carter's initiated with a Sell at Goldman Sachs |
| October 28, 2025 1:43 pm | — | UBS | $33.00 | $32.50 | TheFly | Carter's price target raised to $33 from $26 at UBS |
| October 28, 2025 10:46 am | — | Wells Fargo | $25.00 | $32.51 | TheFly | Carter's price target raised to $25 from $22 at Wells Fargo |
| October 28, 2025 8:57 am | — | Barclays | $26.00 | $32.98 | TheFly | Carter's price target raised to $26 from $23 at Barclays |
| October 14, 2025 9:56 am | — | Barclays | $23.00 | $29.74 | TheFly | Carter's price target raised to $23 from $22 at Barclays |
| April 28, 2025 9:07 am | Paul Kearney | Barclays | $25.00 | $33.87 | TheFly | Carter's initiated with an Underweight at Barclays |
| July 26, 2024 11:57 am | Warren Cheng | Evercore ISI | $60.00 | $57.26 | StreetInsider | Carter's (CRI) PT Lowered to $60 at Evercore ISI |
| April 26, 2024 11:16 am | Zachary Warring | CFRA | $84.00 | $70.01 | StreetInsider | CFRA Upgrades Carter's (CRI) to Buy |
Latest News for CRI
Carter's, Inc. (NYSE: CRI - Get Free Report)'s share price gapped down prior to trading on Friday. The stock had previously closed at $42.07, but opened at $36.42. Carter's shares last traded at $35.1220, with a volume of 1,348,396 shares changing hands. Carter's News Roundup Here are the key news stories impacting Carter's this week:
Carter's, Inc. (CRI) Q4 2025 Earnings Call Transcript
CRI tops Q4 estimates with 7.6% sales growth, but stock sinks over 15% on soft Q1 and 2026 earnings outlook.
Carter's, Inc. reported Q4 results with solid top-line growth but significant margin deterioration due to tariffs and higher costs. FY26 guidance projects modest revenue growth driven by pricing, but persistent gross margin pressure and higher interest expense will weigh on net income. CRI trades at 10x forward earnings, yet secular headwinds like declining fertility and inability to offset tariffs undermine the…
The Shoes & Retail Apparel industry players are riding premiumization and digital momentum, but rising costs and promotions test margins. Stocks like NKE, ADDYY, BIRK, CRI and CAL are positioned for growth.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CRI.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.